Full	O
sequencing	O
analysis	O
of	O
estrogen	O
receptor	O
-	O
alpha	O
gene	O
polymorphism	O
and	O
its	O
association	O
with	O
breast	B-Cancer
cancer	I-Cancer
risk	O
.	O

BACKGROUND	O
:	O

The	O
estrogen	O
receptor	O
plays	O
a	O
critical	O
role	O
in	O
breast	B-Cancer
cancer	I-Cancer
development	O
and	O
progression	O
.	O

So	O
the	O
genetic	O
polymorphism	O
of	O
ER	O
-	O
alpha	O
gene	O
could	O
affect	O
cancer	B-Cancer
risk	O
and	O
phenotype	O
.	O

MATERIALS	O
AND	O
METHODS	O
:	O

We	O
fully	O
sequenced	O
the	O
ER	O
-	O
alpha	O
gene	O
to	O
investigate	O
its	O
single	O
nucleotide	O
polymorphisms	O
(	O
SNPs	O
)	O
in	O
100	O
breast	B-Cancer
cancer	I-Cancer
patients	O
and	O
100	O
controls	O
.	O

RESULTS	O
:	O

Six	O
novel	O
polymorphism	O
in	O
the	O
control	O
and	O
11	O
in	O
cancer	B-Cancer
patients	O
were	O
found	O
.	O

The	O
G	O
/	O
G	O
genotype	O
at	O
C975	O
G	O
and	O
A	O
/	O
A	O
genotype	O
at	O
G1782	O
A	O
had	O
a	O
protective	O
effect	O
against	O
breast	B-Cancer
cancer	I-Cancer
when	O
compared	O
to	O
other	O
genotypes	O
(	O
OR	O
=	O
0	O
.	O
3	O
and	O
0	O
.	O
3	O
,	O
respectively	O
)	O
.	O

975G	O
allele	O
was	O
associated	O
inversely	O
with	O
the	O
p53	O
expression	O
and	O
positively	O
with	O
the	O
bcl	O
-	O
2	O
expression	O
in	O
cancer	B-Cancer
with	O
borderline	O
significance	O
.	O

Combining	O
this	O
result	O
with	O
our	O
previous	O
study	O
,	O
these	O
associations	O
became	O
more	O
significant	O
(	O
p	O
=	O
0	O
.	O
005	O
and	O
0	O
.	O
019	O
,	O
respectively	O
)	O
.	O

CONCLUSION	O
:	O

Polymorphisms	O
in	O
ER	O
-	O
alpha	O
gene	O
can	O
affect	O
the	O
breast	B-Cancer
cancer	I-Cancer
susceptibility	O
and	O
may	O
be	O
related	O
to	O
other	O
protein	O
expression	O
,	O
such	O
as	O
p53	O
and	O
bcl	O
-	O
2	O
.	O

